Literature DB >> 29323532

Identification of CDK2 as a novel target in treatment of prostate cancer.

Xifeng Yin1, Jun Yu2, Yang Zhou1, Chengyue Wang1, Zhimin Jiao1, Zhounan Qian1, Hao Sun1, Binghai Chen1.   

Abstract

AIM: This study aims the potential gene involved in the metastasis of prostate cancer (Pca).
METHODS: PubMed GEO datasets (GSE6605 and GSE6606) were downloaded. We used multiple bioinformatics methods to screen differentially expressed genes in Pca. Gene network was built by STRING and visualized by Cytoscape. All of the hub genes were analyzed by cBioPortal. Inhibition of CDK2 including siRNA, inhibitor and cas9-induced CDK2 knockout was followed by an invasion assay. Downstream genes of CDK2 were analyzed by western blot.
RESULTS: Sequencing data were analyzed to screen the genes with expression alterations. The top genes were validated in our samples. 11 hub genes were screened out. Among these genes, STAT3 and CDK2 were significantly associated with recurrence. Further study suggested that inhibition of CDK2 reduced invasion of Pca cell lines. The invasion ability was rescued after reintroduction of CDK2.
CONCLUSION: These data indicated that CDK2 was a crucial factor in metastasis of Pca and might be a novel therapy target. [Formula: see text].

Entities:  

Keywords:  CDK2; GEO database; PI3K/Akt pathway; cBioPortal; cell cycle; hub genes; metastasis; overall survival; prostate cancer; recurrence

Mesh:

Substances:

Year:  2018        PMID: 29323532     DOI: 10.2217/fon-2017-0561

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  11 in total

1.  Screening a novel six critical gene-based system of diagnostic and prognostic biomarkers in prostate adenocarcinoma patients with different clinical variables.

Authors:  Hadia Munir; Fawad Ahmad; Sajid Ullah; Saeedah Musaed Almutairi; Samra Asghar; Tehmina Siddique; Mostafa A Abdel-Maksoud; Rabab Ahmed Rasheed; Fatma Alzahraa A Elkhamisy; Mohammed Aufy; Hamid Yaz
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

2.  Characterization of Kinase Expression Related to Increased Migration of PC-3M Cells Using Global Comparative Phosphoproteome Analysis.

Authors:  Yan Gao; Yun-Sok Ha; Tae Gyun Kwon; Young-Chang Cho; Sangkyu Lee; Jun Nyung Lee
Journal:  Cancer Genomics Proteomics       Date:  2020 Sep-Oct       Impact factor: 4.069

3.  AZD5438-PROTAC: A selective CDK2 degrader that protects against cisplatin- and noise-induced hearing loss.

Authors:  Santanu Hati; Marisa Zallocchi; Robert Hazlitt; Yuju Li; Sarath Vijayakumar; Jaeki Min; Zoran Rankovic; Sándor Lovas; Jian Zuo
Journal:  Eur J Med Chem       Date:  2021-09-20       Impact factor: 6.514

4.  Integrative Bioinformatics Approaches to Map Potential Novel Genes and Pathways Involved in Ovarian Cancer.

Authors:  S Udhaya Kumar; D Thirumal Kumar; R Siva; C George Priya Doss; Hatem Zayed
Journal:  Front Bioeng Biotechnol       Date:  2019-12-17

5.  Overexpression of EZH2/NSD2 Histone Methyltransferase Axis Predicts Poor Prognosis and Accelerates Tumor Progression in Triple-Negative Breast Cancer.

Authors:  Bo Gao; Xiumin Liu; Zhengjin Li; Lixian Zhao; Yun Pan
Journal:  Front Oncol       Date:  2021-02-16       Impact factor: 6.244

6.  Clinical implications and molecular mechanisms of Cyclin-dependent kinases 4 for patients with hepatocellular carcinoma.

Authors:  Zhong-Liu Wei; Xin Zhou; Chen-Lu Lan; Hua-Sheng Huang; Xi-Wen Liao; Shu-Tian Mo; Yong-Guang Wei; Tao Peng
Journal:  BMC Gastroenterol       Date:  2022-02-22       Impact factor: 3.067

7.  Histone Demethylase KDM5C Drives Prostate Cancer Progression by Promoting EMT.

Authors:  Anna-Lena Lemster; Elisabeth Sievers; Helen Pasternack; Pamela Lazar-Karsten; Niklas Klümper; Verena Sailer; Anne Offermann; Johannes Brägelmann; Sven Perner; Jutta Kirfel
Journal:  Cancers (Basel)       Date:  2022-04-08       Impact factor: 6.575

8.  Polyphenolic Compounds from Lespedeza Bicolor Root Bark Inhibit Progression of Human Prostate Cancer Cells via Induction of Apoptosis and Cell Cycle Arrest.

Authors:  Sergey A Dyshlovoy; Darya Tarbeeva; Sergey Fedoreyev; Tobias Busenbender; Moritz Kaune; Marina Veselova; Anatoliy Kalinovskiy; Jessica Hauschild; Valeria Grigorchuk; Natalya Kim; Carsten Bokemeyer; Markus Graefen; Petr Gorovoy; Gunhild von Amsberg
Journal:  Biomolecules       Date:  2020-03-14

9.  Pharmacophore-based virtual screening, synthesis, biological evaluation, and molecular docking study of novel pyrrolizines bearing urea/thiourea moieties with potential cytotoxicity and CDK inhibitory activities.

Authors:  Ahmed M Shawky; Nashwa A Ibrahim; Mohammed A S Abourehab; Ashraf N Abdalla; Ahmed M Gouda
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

Review 10.  Cyclin-Dependent Kinases (CDK) and Their Role in Diseases Development-Review.

Authors:  Paweł Łukasik; Michał Załuski; Izabela Gutowska
Journal:  Int J Mol Sci       Date:  2021-03-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.